Cargando…
NELSON lung cancer screening study
The Dutch-Belgian Randomized Lung Cancer Screening Trial (Dutch acronym: NELSON study) was designed to investigate whether screening for lung cancer by low-dose multidetector computed tomography (CT) in high-risk subjects will lead to a decrease in 10-year lung cancer mortality of at least 25% compa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
e-Med
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266562/ https://www.ncbi.nlm.nih.gov/pubmed/22185865 http://dx.doi.org/10.1102/1470-7330.2011.9020 |
_version_ | 1782222188645974016 |
---|---|
author | Zhao, Ying Ru Xie, Xueqian de Koning, Harry J Mali, Willem P Vliegenthart, Rozemarijn Oudkerk, Matthijs |
author_facet | Zhao, Ying Ru Xie, Xueqian de Koning, Harry J Mali, Willem P Vliegenthart, Rozemarijn Oudkerk, Matthijs |
author_sort | Zhao, Ying Ru |
collection | PubMed |
description | The Dutch-Belgian Randomized Lung Cancer Screening Trial (Dutch acronym: NELSON study) was designed to investigate whether screening for lung cancer by low-dose multidetector computed tomography (CT) in high-risk subjects will lead to a decrease in 10-year lung cancer mortality of at least 25% compared with a control group without screening. Since the start of the NELSON study in 2003, 7557 participants underwent CT screening, with scan rounds in years 1, 2, 4 and 6. In the current review, the design of the NELSON study including participant selection and the lung nodule management protocol, as well as results on validation of CT screening and first results on lung cancer screening are described. |
format | Online Article Text |
id | pubmed-3266562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | e-Med |
record_format | MEDLINE/PubMed |
spelling | pubmed-32665622013-10-03 NELSON lung cancer screening study Zhao, Ying Ru Xie, Xueqian de Koning, Harry J Mali, Willem P Vliegenthart, Rozemarijn Oudkerk, Matthijs Cancer Imaging Lung Cancer Screening The Dutch-Belgian Randomized Lung Cancer Screening Trial (Dutch acronym: NELSON study) was designed to investigate whether screening for lung cancer by low-dose multidetector computed tomography (CT) in high-risk subjects will lead to a decrease in 10-year lung cancer mortality of at least 25% compared with a control group without screening. Since the start of the NELSON study in 2003, 7557 participants underwent CT screening, with scan rounds in years 1, 2, 4 and 6. In the current review, the design of the NELSON study including participant selection and the lung nodule management protocol, as well as results on validation of CT screening and first results on lung cancer screening are described. e-Med 2011-10-03 /pmc/articles/PMC3266562/ /pubmed/22185865 http://dx.doi.org/10.1102/1470-7330.2011.9020 Text en © 2011 International Cancer Imaging Society |
spellingShingle | Lung Cancer Screening Zhao, Ying Ru Xie, Xueqian de Koning, Harry J Mali, Willem P Vliegenthart, Rozemarijn Oudkerk, Matthijs NELSON lung cancer screening study |
title | NELSON lung cancer screening study |
title_full | NELSON lung cancer screening study |
title_fullStr | NELSON lung cancer screening study |
title_full_unstemmed | NELSON lung cancer screening study |
title_short | NELSON lung cancer screening study |
title_sort | nelson lung cancer screening study |
topic | Lung Cancer Screening |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266562/ https://www.ncbi.nlm.nih.gov/pubmed/22185865 http://dx.doi.org/10.1102/1470-7330.2011.9020 |
work_keys_str_mv | AT zhaoyingru nelsonlungcancerscreeningstudy AT xiexueqian nelsonlungcancerscreeningstudy AT dekoningharryj nelsonlungcancerscreeningstudy AT maliwillemp nelsonlungcancerscreeningstudy AT vliegenthartrozemarijn nelsonlungcancerscreeningstudy AT oudkerkmatthijs nelsonlungcancerscreeningstudy |